Chemical cardioversion of atrial fibrillation with intravenous dofetilide
Authors:
- Greg LipGLGreg Lip
- Alan P. RaeARAlan P. Rae
- Stuart M. CobbeSCStuart M. Cobbe
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 49 (2) , 159-166
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clinical and electrophysiologic effects of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with angina pectorisThe American Journal of Cardiology, 1992
- Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassayJournal of Pharmaceutical and Biomedical Analysis, 1991
- QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the RabbitJournal of Cardiovascular Pharmacology, 1990
- Treatment of torsade de pointes with magnesium sulfate.Circulation, 1988
- A reference data base for multilead electrocardiographic computer measurement programsJACC, 1987
- Long QT: Good, bad or indifferent?JACC, 1984
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982
- Cardiovascular manifestations of tricyclic antidepressant overdoseAmerican Heart Journal, 1980
- Epidemiologic assessment of chronic atrial fibrillation and risk of strokeNeurology, 1978
- Torsade De Pointes, an atypical ventricular tachycardia.Heart, 1976